Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia

K. Reppe, P. Radünzel, T. Tschernig, T. Wolff, A. Gruber, N. Suttorp, M. Witzenrath (Berlin, Homburg/Saar, Germany)

Source: Annual Congress 2012 - Hot topics in respiratory infections
Session: Hot topics in respiratory infections
Session type: Oral Presentation
Number: 2816
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Reppe, P. Radünzel, T. Tschernig, T. Wolff, A. Gruber, N. Suttorp, M. Witzenrath (Berlin, Homburg/Saar, Germany). Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2816

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with streptococcus pneumoniae resulted in a synergistic effect on neutrophil influx in mice
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


The impact of time on the systemic inflammatory response in pneumococcal pneumonia
Source: Eur Respir J 2010; 35: 614-618
Year: 2010



Heterologous infection causes pneumonia and impairs alveolar macrophage function in mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008

A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001

Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia
Source: Eur Respir J 2010; 36: 285
Year: 2010



Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016

Downregulation of RTI40 /T1α protein in pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004

PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008


MAIT cells protect against fatal intracellular pulmonary legionella infection via IFN-?
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017


Factors associated with inflammatory cytokine patterns in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 393
Year: 2011